Please login to the form below

Not currently logged in
Email:
Password:

stem cells

This page shows the latest stem cells news and features for those working in and with pharma, biotech and healthcare.

Mesoblast expands compassionate use COVID-19 programme

Mesoblast expands compassionate use COVID-19 programme

The drug, an allogeneic mesenchymal stem cell (MSC) product candidate dubbed remestemcel-L, will now be available for children between the ages of two months and 15 years old infected with ... Remestemcel-L is comprised of culture-expanded mesenchymal

Latest news

More from news
Approximately 5 fully matching, plus 109 partially matching documents found.

Latest Intelligence

  • AI and genomics: a revolution in drug discovery and development AI and genomics: a revolution in drug discovery and development

    The next step of the process was to work with a partner to run the most promising targets through various confirmatory assays, including phenotypic assessments using stem cells from patients.

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    Replenish. Replace. Rejuvenate. Stem cells can generate vital growth factors to naturally reduce inflammation, increase muscle mass, repair joints, grow hair and boost the immune system, replenishing the body. ... The root causes of ageing are being

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    CTX001 is an ex vivo therapy, meaning. the CRISPR technology is used to modify haematopoietic stem cells outside the body to express foetal haemoglobin, and then reinfused into the patient. ... hope was that - without the brake of PD-1 – the edited

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    Kathy Niakan is a group leader at London's academic research hub The Francis Crick Institute.and is investigating the mechanisms of lineage specification in human embryos and stem cells. ... of infertility, miscarriages and developmental disorders, and

  • Deal Watch January 2018

    Takeda moves in neurodegenerative diseases and stem cell therapy. Meanwhile Takeda, ranked 4. ... Option exercise (2 options). 640. TiGenix/Takeda. Cx601, lead asset, allogeneic expanded adipose-derived stem cells (eASC) locally administered for

More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics